We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Petiq Inc (PETQ) USD0.001 A

Sell:$30.77 Buy:$30.78 Change: $0.045 (0.15%)
NASDAQ:0.20%
Market closed |  Prices as at close on 17 September 2024 | Switch to live prices |
Sell:$30.77
Buy:$30.78
Change: $0.045 (0.15%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 17 September 2024 | Switch to live prices |
Sell:$30.77
Buy:$30.78
Change: $0.045 (0.15%)
Market closed |  Prices as at close on 17 September 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segment’s services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.

Contact details

Address:
Petiq Llc, 230 E. Riverside Dr.
EAGLE
83616
United States
Telephone:
+1 (208) 9398900
Website:
https://petiq.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
PETQ
ISIN:
US71639T1060
Market cap:
$918.39 million
Shares in issue:
29.89 million
Sector:
Health Care Distributors
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • McCord Christensen
    Chairman of the Board, Chief Executive Officer
  • Michael Smith
    President, Chief Operating Officer
  • Zvi Glasman
    Chief Financial Officer
  • William Carter
    Executive Vice President, General Counsel
  • John Pearson
    Executive Vice President - Services and Manufactured Products

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.